Personalized 12-week digital exercise program to correct knee movement after ACL reconstruction
Official title: Personalized Digital Training Intervention to Reduce Inflammation by Correcting Pathological Movement Patterns in Pre-stage Knee Osteoarthritis (OA)
Run by Charite University, Berlin, Germany · NCT06596824 · Data updated 2026-11-12
This program will try a 12-week sensor-guided exercise plan for adults 8–12 weeks after ACL reconstruction to correct harmful knee movements and reduce joint inflammation that can lead to early knee osteoarthritis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Charite University, Berlin, Germany Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy |
| Locations | 2 sites (Berlin and 1 other locations) |
| Status | Recruiting |
| Started | September 1, 2024 |
| Main results expected | October 1, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | March 2, 2026 |
| Trial ID | NCT06596824 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 18–50 who had a primary unilateral ACL reconstruction, can complete baseline testing 8–12 weeks after surgery, and meet BMI and activity-level criteria without signs of established knee OA.
✕Probably not a fit
Patients with established radiographic knee OA, BMI ≥30, inflammatory arthropathies, previous surgeries on the study knee, or who cannot attend required assessments are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional program delivers a personalized, sensor-based training regimen over 12 weeks aimed at normalizing pathological knee movement patterns after primary ACL reconstruction. Participants complete a baseline assessment between 8 and 12 weeks post-op and then follow digitally guided exercises with real-time feedback from wearable sensors. The intervention targets pre-stage osteoarthritis by reducing abnormal joint loading and markers of inflammation through movement retraining. Eligibility limits include ages 18–50, BMI <30, unilateral primary ACL reconstruction, and no radiographic joint-space narrowing consistent with established OA.
Why it matters
Potential benefit: If successful, the program could lower joint inflammation and delay or prevent early knee osteoarthritis after ACL reconstruction.
How similar studies have gone: Some rehabilitation programs using biofeedback and targeted movement training have improved function after ACL reconstruction, but using wearable sensor-guided personalized training specifically to reduce inflammation and prevent OA is relatively novel and not yet proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Signed written informed consent * Adult subjects between 18 to 50 years old at the time of screening * Primary ACL reconstruction within a maximum of 6 months after a unilateral ACL injury * Complete baseline assessment between 8 and 12 weeks after ACL reconstruction Exclusion Criteria: * Significant trauma to a weight-bearing joint within 12 months prior to study initiation (excluding the ACL injury) * Previous surgeries on the study knee (except for the ACL reconstruction) * Signs of knee OA as defined by the OARSI-Joint Space Narrowing (JSN) Score of two or more (standing AP x-ray) * Physical activity level: Tegner activity score before injury of 0-2 (very low activity) or 8-10 (very high activity) * Body mass index ≥ 30 kg/m2; * Inflammatory arthropathies; * Immunosuppression due to illness or medication; * Sepsis or hemostasis disorders; * Severe uncontrolled inflammatory disease or autoimmune disease (e.g., ulcerative colitis, Crohn's disease, etc.); * Having malignancy and undergoing treatment including chemotherapy, radiotherapy, or immunotherapy; * Contraindications for MRI, including pacemakers, defibrillators, metal implants, pregnancy, sensorineural hearing loss above 30 dB, tinnitus and claustrophobia * Unable to freely give their informed consent (e.g., individuals under legal guardianship). * Currently enrolled in or has not yet completed a period of at least 5 times as the half-life time of the drug used in the previous trial since ending other investigational device or drug trial(s) * Patients who are dependent on the sponsor, investigator, or study site; * Pregnant or breast-feeding women or women of childbearing potential not protected by an effective contraceptive method of birth control (defined as pearl index \< 1); * Any form of substance abuse, psychiatric disorder, or other condition that, in the opinion of the Investigator, may invalidate communication with the Investigator and/or designated study personnel; * Patients who are committed to an institution by virtue of an order issued by either the judicial or the administrative authorities;
Where it's running
-
Charité - Universitätsmedizin Berlin, BeMoveD - Berlin Movement Diagnostics
Berlin, Germany Recruiting -
Charité - Universitätsmedizin Berlin
Berlin, Germany Recruiting
Study contacts
- Study coordinator: Winkler, Prof. Dr.med.
- Email: tobias.winkler@charite.de
- Phone: +49 30 450 559084
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Plyometric training added to standard rehab after ACL reconstruction
This study tests whether adding plyometrics to the usual rehab after ACL reconstruction helps improve leg strength and function in adults aged 18–40.
-
Isokinetic vs Plyometric Training After ACL Reconstruction
This trial tests whether isokinetic or plyometric training, added after standard rehab, best improves strength, function, and patient-reported outcomes in adults 18–40 after ACL reconstruction.
-
ACL reconstruction using the Over-The-Top technique with either metal staples or soft anchors
This study tests whether using a suture-based fixation (soft anchors) during OTT ACL reconstruction works as well as metal staples for graft stability in adults aged 18–50.
-
Medial knee osteoarthritis: inside vs outside corticosteroid injection
This study tests whether injecting a steroid inside the knee joint leads to different pain results than injecting it on the outside of the knee in people with medial knee osteoarthritis.
-
Platelet-rich plasma added to hyaluronic acid for knee osteoarthritis
This study tests whether a single injection of hyaluronic acid plus autologous platelet-rich plasma helps reduce knee OA symptoms more than hyaluronic acid alone in adults with moderate knee OA.
-
Hyaluronic Acid Plus PRP Injection for Knee Osteoarthritis
This study tests whether a single HA injection combined with a patient’s own PRP is better at easing knee OA pain than HA alone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.